CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Income Tax Assets, Net
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Deferred Income Tax Assets, Net of $53.83 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-08-05
- 2026-06-27: Deferred Income Tax Assets, Net $53.83M.
- 2026-03-28: Deferred Income Tax Assets, Net $88.60M.
- 2025-12-27: Deferred Income Tax Assets, Net $67.33M.
- 2025-09-27: Deferred Income Tax Assets, Net $36.91M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2026-06-27 | $53.83M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $88.60M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $67.33M 10-Q · filed 2026-08-05 |
| 2025-09-27 | $36.91M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $46.94M 10-Q · filed 2025-08-06 |
| 2025-03-29 | $48.79M 10-Q · filed 2025-05-07 |
| 2024-12-28 | $42.18M 10-K · filed 2026-02-18 |
| 2024-09-28 | $37.96M 10-Q · filed 2024-11-06 |
| 2024-06-29 | $36.11M 10-Q · filed 2024-08-07 |
| 2024-03-30 | $36.92M 10-Q · filed 2024-05-09 |
| 2023-12-30 | $40.28M 10-K · filed 2025-02-19 |
| 2023-09-30 | $34.26M 10-Q · filed 2023-11-08 |
| 2023-07-01 | $38.54M 10-Q · filed 2023-08-09 |
| 2023-04-01 | $41.02M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $41.26M 10-K · filed 2024-02-14 |
| 2022-09-24 | $39.72M 10-Q · filed 2022-11-02 |
| 2022-06-25 | $42.47M 10-Q · filed 2022-08-03 |
| 2022-03-26 | $43.40M 10-Q · filed 2022-05-04 |
| 2021-12-25 | $40.23M 10-K · filed 2023-02-22 |
| 2021-09-25 | $41.12M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $31.86M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $35.46M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $37.73M 10-K · filed 2022-02-16 |
| 2020-09-26 | $39.52M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $42.76M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $42.75M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $44.66M 10-K · filed 2021-02-17 |
| 2019-09-28 | $44.83M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $33.48M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $23.77M 10-Q · filed 2019-05-07 |
| 2018-12-29 | $23.39M 10-K · filed 2020-02-11 |
| 2018-09-29 | $24.56M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $27.23M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $26.24M 10-Q · filed 2018-05-10 |
| 2017-12-30 | $22.65M 10-K · filed 2019-02-13 |
| 2017-09-30 | $30.86M 10-Q · filed 2017-11-09 |
| 2017-07-01 | $30.49M 10-Q · filed 2017-08-09 |
| 2016-12-31 | $28.75M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |